Cryo Cell International (CCEL) Cash from Financing Activities (2011 - 2026)

Cryo Cell International has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$740290.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 26.3% year-over-year to -$740290.0; the TTM figure through Feb 2026 stood at -$4.5 million (down 77.64% YoY), while the FY2025 annual figure was -$4.7 million, down 384.64% from the prior year.
• Cash from Financing Activities rose to -$740290.0 in Q1 2026, from -$937340.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for CCEL reached as high as $8.7 million in Q3 2022 and fell as low as -$5.6 million in Q4 2022.
• The 5-year median for Cash from Financing Activities is -$772847.0 (2023), against an average of -$493508.2.
• The widest YoY moves for Cash from Financing Activities: up 1217.08% in 2022, down 1476.04% in 2022.
• A 5-year view of Cash from Financing Activities shows it stood at -$5.6 million in 2022, then surged by 72.32% to -$1.5 million in 2023, then surged by 56.0% to -$677821.0 in 2024, then slumped by 38.29% to -$937340.0 in 2025, then increased by 21.02% to -$740290.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$740290.0, -$937340.0, and -$3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.